PMID- 18948835
OWN - NLM
STAT- MEDLINE
DCOM- 20090428
LR  - 20181217
IS  - 1536-4828 (Electronic)
IS  - 0885-3177 (Linking)
VI  - 38
IP  - 2
DP  - 2009 Mar
TI  - Does somatostatin confer insulinostatic effects of neuromedin u in the rat 
      pancreas?
PG  - 208-12
LID - 10.1097/MPA.0b013e31818d9095 [doi]
AB  - OBJECTIVES: Neuromedin U (NmU) is a neuropeptide with anorexigenic activity. Two 
      receptor subtypes (NmUR1 and NmUR2) confer the effects of NmU on target cells. We 
      have recently demonstrated that NmU reduces insulin secretion from isolated 
      pancreatic islets. Aim of our current study is to investigate the role of 
      somatostatin at mediating the effects of NmU on insulin secretion. METHODS: 
      Expression of NmU in the pancreas was detected by immunohistochemistry. Insulin 
      and somatostatin secretion from in situ perfused rat pancreas and isolated 
      pancreatic islets was measured by radioimmunoassay. The paracrine effects of 
      somatostatin within pancreatic islets were blocked by cyclosomatostatin, a 
      somatostatin receptor antagonist. RESULTS: Receptor subtype NmUR1, but not NmUR2, 
      was expressed in the endocrine pancreas, predominantly in the periphery. 
      Neuromedin U reduced insulin secretion from in situ perfused rat pancreas and 
      stimulated somatostatin secretion from isolated pancreatic islets. Neuromedin U 
      stimulated somatostatin secretion at both physiological and supraphysiological 
      glucose concentrations. Cyclosomatostatin increased insulin secretion and reduced 
      NmU-induced inhibition of insulin secretion. CONCLUSIONS: Neuromedin U reduces 
      insulin and increases somatostatin secretion. Blockade of somatostatin action 
      abolishes the inhibition of insulin secretion by NmU. The results of the study 
      suggest that somatostatin mediates the inhibitory action of NmU on insulin 
      secretion.
FAU - Kaczmarek, Przemyslaw
AU  - Kaczmarek P
AD  - Department of Animal Physiology and Biochemistry, August Cieszkowski University 
      of Agriculture, Poznan, Poland.
FAU - Malendowicz, Ludwik K
AU  - Malendowicz LK
FAU - Fabis, Marzena
AU  - Fabis M
FAU - Ziolkowska, Agnieszka
AU  - Ziolkowska A
FAU - Pruszynska-Oszmalek, Ewa
AU  - Pruszynska-Oszmalek E
FAU - Sassek, Maciej
AU  - Sassek M
FAU - Wojciechowicz, Tatiana
AU  - Wojciechowicz T
FAU - Szczepankiewicz, Dawid
AU  - Szczepankiewicz D
FAU - Andralojc, Karolina
AU  - Andralojc K
FAU - Szkudelski, Tomasz
AU  - Szkudelski T
FAU - Strowski, Mathias Z
AU  - Strowski MZ
FAU - Nowak, Krzysztof W
AU  - Nowak KW
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Pancreas
JT  - Pancreas
JID - 8608542
RN  - 0 (Insulin)
RN  - 0 (Neuropeptides)
RN  - 0 (Receptors, Neurotransmitter)
RN  - 0 (neuromedin U receptor)
RN  - 117505-80-3 (neuromedin U)
RN  - 51110-01-1 (Somatostatin)
SB  - IM
MH  - Animals
MH  - Insulin/*metabolism
MH  - Insulin Secretion
MH  - Neuropeptides/*pharmacology
MH  - Pancreas/*drug effects/metabolism
MH  - Rats
MH  - Rats, Wistar
MH  - Receptors, Neurotransmitter/analysis/physiology
MH  - Somatostatin/*physiology
EDAT- 2008/10/25 09:00
MHDA- 2009/04/29 09:00
CRDT- 2008/10/25 09:00
PHST- 2008/10/25 09:00 [pubmed]
PHST- 2009/04/29 09:00 [medline]
PHST- 2008/10/25 09:00 [entrez]
AID - 00006676-200903000-00017 [pii]
AID - 10.1097/MPA.0b013e31818d9095 [doi]
PST - ppublish
SO  - Pancreas. 2009 Mar;38(2):208-12. doi: 10.1097/MPA.0b013e31818d9095.